Skip to content
Pharma
Search
  • Contact
  • Downloads
  • Locations
  • Career
  • About us
  • Products
  • Applications
    Applications

    Find the fitting packaging for you specific product

    To Applications
      • Oral Drug Delivery
        Oral Drug Delivery

        Packaging materials for peroral drugs

      • Injectable Drug Delivery
        Injectable Drug Delivery

        Packaging materials for parenteral drugs

      • Pulmonary Drug Delivery
        Pulmonary Drug Delivery

        Packaging materials for inhalation products

      • Transmucosal / Transdermal Drug Delivery
        Transmucosal / Transdermal Drug Delivery

        Packaging materials for topical drugs

      • Medical Devices
        Medical Devices

        Packaging material to protect medical devices

      • Additional Features
        Additional Features
  • Technology
    Technology To Technology
      • Digital Printing
        Digital Printing

        Quicker, shorter and more flexible than ever

  • Services
    Services To Services
      • Live stress check
        Live stress check

        Assessing the limits and potential of your pharma packaging solutions

      • Package characterization
        Package characterization

        Powerful insights into pharmaceutical packaging

      • Cross-permeation simulation
        Cross-permeation simulation

        Determination of gas and vapor ingress through sealing layers of pharma packaging

      • Thermal impact simulation
        Thermal impact simulation

        Measuring the unmeasurable: heat stress of goods in packaging lines

      • Forming simulation
        Forming simulation

        Fast track to evaluate materials, designs and tools

      • Extractables analysis
        Extractables analysis

        Supporting your needs in regulatory affairs

      • Reel Calculator
        Reel Calculator

        Calculate packaging material in seconds.

  • Sustainability
  • Blog
  • Search
  1. Pharma
  2. Blog
  3. Behind the scenes
  4. Keeping medicines safe
nitrosamines in pharmaceutical packaging
Behind the scenes

Keeping medicines safe

Constantia Flexibles addresses concerns about nitrosamines in pharmaceutical packaging

June 13, 2019

Following a recent guidance issued by the European Medicines Agency, questions have arisen as to the possible role of printing primers and inks in the formation of nitrosamines in human medicines. Constantia Flexibles would like to provide more clarity for our customers on this topic and reaffirm that our number one priority is delivering reliable packaging products that meet the highest quality standards and ensure the safety and compliance of all marketed products.

After minimal traces of nitrosamines were detected in certain medicines over the past year, the European Medicines Agency (EMA) has urged manufacturers to evaluate the risk of contamination in their own products. The Agency provided relevant guidance on October 9, 2019 in a document entitled “Questions and Answers on Information on Nitrosamines for Marketing Authorization Holders.” The document outlines eight possible sources of nitrosamine contamination, among them what EMA refers to as “certain packaging materials.” This section cites the hypothesis of one Marketing Authorization Holder (MAH) suggesting that “lidding foil containing nitrocellulose printing primer may react with amines in printing ink to generate nitrosamines, which would be transferred to the product under certain packaging process conditions.” 

Let us first reassure you that extremely low levels of nitrosamines pose only a minimal risk to humans and, as a result, no regulators have sought to restrict, ban, or recall any of these packaging materials. Second, it is important to note that these contaminants are not being introduced intentionally during the packaging process. Nitrosamines are organic chemical compounds that form when nitrosating agents react with aliphatic amines. In theory, nitrocellulose-based inks and printing primers could become nitrosating agents under certain circumstances, for example at elevated temperatures like those present in the heat-sealing process for blister packs. And, in theory, those agents could react with secondary amines present in the production process, for example from certain commercial organic pigments or UV inks.

Based on the available data, we believe that both the health risks associated with trace amounts of nitrosamine and the likelihood of nitrosamines being transferred to medicines during the packaging process are very low. What is more, many products within Constantia Flexibles’s pharmaceutical portfolio do not contain the precise combination of raw materials theoretically needed to form the chemical compound in question. At our facilities and across the industry, there is a wide range of primary packaging materials in use today that totally eliminates the risk of nitrosamine formation. 

In closing, we would like our customers to rest assured that the medicines and the packaging products on today’s markets are safe and that we have reliable systems in place to make certain they stay that way. If you have any further questions about Constantia Flexibles’s blister lidding solutions that address the issues raised here, please do not hesitate to get in touch with us at pharma@cflex.com.

Lets save lives today
Back to main navigation
  • Products & Applications
    • All Products
    • Oral Drug Delivery
    • Injectable Drug Delivery
    • Transmucosal / Transdermal Drug Delivery
    • Pulmonary Drug Delivery
    • Medical Devices
    • Additional features
  • Technology
    • Digital Printing
  • Services
    • Live stress check
    • Package characterization
    • Cross-permeation simulation
    • Thermal impact simulation
    • Forming simulation
    • Extractables analysis
  • Blog
  • Social media Facebook
  • Social media LinkedIn
  • Social media Xing
  • Social media Youtube
© 2022 Constantia Flexibles
  • Visit CFlex Constantia Flexibles Consumer
  • Visit CFlex Constantia Flexibles Group
  • Legal imprint
  • General terms & conditions
  • Privacy Policy
  • Contact
  • Newsletter
  • Cookies settings